WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark ONCODIANOVA was filed as Word mark on 07/26/2018 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1446813 |
| Register number | 302018101624 |
| Countries | 
|
| Base trademark |
No. 30 2018 101 624,
March 15, 2018
|
| Application date | July 26, 2018 |
| Expiration date | July 26, 2028 |
Trademark owner
Warburgstr. 45
20354 Hamburg
DE
20354 Hamburg
DE
Trademark representatives
Poststr. 33
20354 Hamburg
DE
goods and services
01
Chemical substances, chemical materials and chemical
preparations, and natural chemical elements; chemical
compositions and materials for use in science; proteins for
use in science; proteins for use in industry; proteins for
binding antibodies [other than for medical use]; proteins
for detecting antibodies [other than for medical purposes];
antibodies for scientific purposes, other than for medical
or veterinary use; antibody reagents for scientific
purposes; monoclonal antibody reagents, other than for
medical use; monoclonal antibodies for scientific use;
monoclonal antibodies for diagnostic use [other than for
medical purposes], in particular for identifying and
classifying tumour cells; diagnostic preparations, other
than for medical or veterinary purposes; diagnostic
reagents, other than for medical laboratory use [in
particular antibody reagents and monoclonal antibody
reagents]; diagnostic substances, other than for medical
use; chemical reagents for use in diagnostic tests, other
than for medical or veterinary use; liquid buffers; salts
[chemical preparations]; reagents for use in the development
of monoclonal antibodies [other than for medical or
veterinary purposes], in particular antigens and immunogens;
hybridomas for producing monoclonal antibodies [other than
for medical or veterinary purposes]
05
Medical and veterinary preparations; diagnostic preparations
for medical or veterinary purposes; diagnostic reagents for
medical use; diagnostic substances for medical use; clinical
diagnostic reagents; in vitro diagnostic preparations for
medical use; chemical reagents for medical diagnostic
purposes [in particular liquid buffers]; reagents for use in
diagnostic tests for medical purposes [in particular
antibody reagents and monoclonal antibody reagents];
diagnostic preparations and materials [in particular for
pathology, medical histology and in vitro diagnostics], in
particular antibodies, monoclonal antibodies, proteins for
binding antibodies, proteins for detecting antibodies;
diagnostic preparations and materials, in particular
monoclonal antibodies for diagnostic use [in particular for
identifying and classifying tumour cells]; reagents for
developing monoclonal antibodies [for medical,
pharmaceutical or veterinary purposes], in particular
antigens and immunogens; hybridomas for producing monoclonal
antibodies [for medical, pharmaceutical or veterinary
purposes]; pharmaceuticals, in particular antibodies [in
particular monoclonal antibodies for immunotherapy]
35
Retailing and wholesaling [in particular online retail
services] in relation to chemical substances, chemical
materials and chemical preparations, and natural elements;
retailing and wholesaling [in particular online retail
services] in relation to chemical compounds and materials
for use in science; retailing and wholesaling [in particular
online retail services] in relation to medical and
veterinary preparations; retailing and wholesaling [in
particular online retail services] in relation to proteins,
proteins for binding antibodies, proteins for detecting
antibodies; retailing and wholesaling [in particular online
retail services] in relation to antibodies, monoclonal
antibodies [in particular for diagnostic use, in particular
for identifying and classifying tumour cells]; retailing and
wholesaling [in particular online retail services] in
relation to diagnostic preparations and materials,
diagnostic preparations, diagnostic reagents [in particular
antibody reagents and monoclonal antibody reagents];
retailing and wholesaling [in particular online retail
services] in relation to reagents for clinical diagnostics,
in vitro diagnostic preparations; retailing and wholesaling
[in particular online retail services] in relation to
diagnostic substances, chemical reagents for diagnostic
tests, liquid buffers, salts [chemical preparations];
retailing and wholesaling [in particular online retail
services] in relation to reagents for developing monoclonal
antibodies [in particular antigens and immumogens],
hybridomas for producing monoclonal antibodies; retailing
and wholesaling [in particular online retail services] in
relation to pharmaceuticals, in particular antibodies [in
particular monoclonal antibodies for immunotherapy]
42
Scientific and technological services; research and
development services; medical and pharmaceutical research
services [in particular in the field of oncology]; research
and development in the field of diagnostic preparations, in
particular development of antibody-based tests and analyses
[in particular for identifying and classifying tumour
cells]; research and development in the field of diagnostic
preparations, in particular in relation to production of
antibody-based tests and analyses [in particular for
identifying and classifying tumour cells]; research and
development for the pharmaceutical industry [in particular
in relation to pharmacological studies and development of
therapeutic antibodies]; research and development in the
field of biotechnology; research and development services in
the field of antibody technology; chemical and biological
laboratory services relating to the production of
antibodies, in particular development of monoclonal
antibodies and in relation to production of monoclonal
antibodies [in particular for research and diagnostics], in
particular for identifying and classifying tumour cells;
research and development in relation to manufacturing and
validating immunogens; chemical and biological laboratory
services in relation to immunising mice, rats and rabbits;
chemical and biological laboratory services in relation to
manufacturing, selecting and cloning hybridomas; chemical
and biological laboratory services in relation to providing
and characterising monoclonal antibodies; consultancy and
information in relation to the aforesaid services, included
in this class
44
Medical services; medical testing services relating to the
diagnosis and treatment of disease [in particular in the
field of oncology]; medical diagnostic services [conducting
of tests and analyses, in particular in the fields of
pathology, medical histology and in vitro diagnostics], in
particular conducting of antibody-based tests and analyses;
medical diagnostic services [conducting of tests and
analyses], in particular immunohistochemical and microscopic
tests and analyses, in particular for identifying and
classifying tumour cells; consultancy and information in
relation to the aforesaid services, included in this class;
consultancy and information services relating to
biopharmaceutical products; consultancy and information
services relating to medical products; consultancy and
information services relating to pharmaceutical products
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| July 23, 2020 | 2020/31 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| March 28, 2020 | 2020/14 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| February 27, 2020 | 2020/9 Gaz | JP | Rejection |
| December 17, 2019 | 2019/51 Gaz | CH | Rejection |
| May 6, 2019 | 2019/20 Gaz | CN | Rejection |
| February 28, 2019 | 2019/9 Gaz | US | Rejection |
| July 26, 2018 | 2019/3 Gaz | DE | Registration |
ID: 141446813